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INTRODUCTION
Risk factors for stomach cancer include infection with Heli-
cobacter pylori, genetic factors, dietary intake, and cigarette
smoking [1, 2]. Dietary intake has been suggested as an espe-
cially important factor in the etiology of stomach cancer when
explaining geographic, socioeconomic, and chronologic dis-
crepancies in the incidence [3].
Presently, tea is the most widely consumed beverage in
the world aside from water [4]. Tea is generally consumed in
the form of green (20%), oolong (2%), or black (78%) tea,
all of which originate from the leaves of the plant Camellia
sinensis [5]. Among the teas, green tea contains many poly-
phenols known as catechins, such as epigallocatechin-3 gal-
late (EGCG), epigallocatechin (EGC) and epicatechin-3 gal-
late (ECG). Tea and the constituents of tea have been shown
to inhibit tumorigenesis in many animal models, including
those for cancer of the skin, lung, oral cavity, esophagus, sto-
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mach, small intestine, colon, liver, pancreas, bladder, breast
and prostate [6]. Mechanisms that have been proposed for
the biological activities of tea polyphenols include antioxidant
activities, induction or inhibition of drug metabolizing enzy-
mes, inhibition of arachidonic acid metabolism, inhibition of
cell proliferation, induction of apoptosis, and inhibition of
DNA methyltransferase, dihydrofolate reductase (DHFR),
protease, and telomerase [7]. 
Ahn et al. [8] reported significant favorable responses in
women with human papilloma virus-infected cervical lesions
treated with oral and/or topical green tea extract preparations,
and Bettuzzi et al. [9] also reported that 600 mg of daily cat-
echin extract derived from green tea had a statistically signifi-
cant protective effect in patients with high-grade prostate in-
traepithelial neoplasia. Over the last three decades, a number
of epidemiologic studies were conducted to investigate the
association between green tea consumption and stomach can-
cer risk in human subjects. Recent narrative reviews have
concluded that epidemiologic studies did not provide consis-
tent evidence to support tea as a chemopreventive agent aga-
inst stomach cancer development [10, 11]. There has never
been any quantitative attempt, however, to summarize the
results of studies exploring a possible green tea-stomach can-
cer association. The aim of this study is to elucidate the asso-
ciation between green tea consumption and stomach cancer
risk by meta-analysis of previously published data. 
MATERIALS AND METHODS
Literature search and inclusion criteria
To search for observational studies of green tea consump-
tion in relation to stomach cancer risk, we conducted a litera-
ture search using the following medical databases, MEDLINE,
THE COCHRANE LIBRARY, and RISS (to search for Kore-
an literature); we restricted the search to papers published in
English, Japanese or Korean, which were published up to May
2007. For the search, we identified articles using such medi-
cal subject-heading terms as “stomach neoplasms”, “tea” or
“catechin” or the keywords: “stomach cancer”, “gastric can-
cer”, “green tea”, or “catechin”. In addition, we also conduct-
ed a manual search of reference lists from the retrieved papers
for further relevant publications. 
For inclusion in the meta-analysis, the identified articles
had to meet the following criteria: 1) they had to be human
studies, not laboratory or animal studies; 2) they had to doc-
ument the daily consumption of the natural green tea prod-
uct, not of green tea extracts or supplements; 3) the outcome
of interest had to be an incidence of stomach cancer; 4) full-
text articles from the study had to be accessible to the authors.
We excluded studies which did not provide information on
(i) the number of stomach cancer cases and controls studied
and/or (ii) the odds ratio (OR) or relative risk (RR) and its
corresponding 95% confidence interval (CI) for highest ver-
sus non/lowest level of tea intake. When more than one stud-
ies analyzed the same dataset, only the most recent study
was included in the analysis. These articles were reviewed
independently by two authors (H.K. and C.M.N.) to deter-
mine whether the articles met the inclusion criteria of the
present study. 
Statistical analysis
Study-specific ORs/RRs and the corresponding 95% CIs
for highest versus non/lowest green tea consumption levels
were extracted from the publications. Crude OR was calcu-
lated from the numbers of cases and controls in one study
[12] because the analysis included a previously published
data [13]. If a study provided separate OR or RR estimates
for men and women, we treated them as two different stud-
ies. For a study that provided two OR or RR estimates based
on hospital and population controls, we used the estimate
derived from the population control. The standard errors of
the natural logarithms of the ORs or RRs were calculated from
the 95% CIs of the ORs/RRs and used for the meta-analysis.
Statistical computing was performed using the STATA statis-
tical software (version 8.0; College Station, TX, USA).
Possible heterogeneity of effect sizes across the studies was
examined using the Q statistic [14]. Statistical significance for
the heterogeneity test was defined as p<0.10 rather than the
conventional level of 0.05 because of the low power of this
test [15]. When there was significant heterogeneity among
effect sizes, the random effect model was used to calculate
the summary RR/OR. When the results of the studies were
homogenous, the fixed effect model was used instead. The
causes of heterogeneity were further explored through sub-
group analyses.
For calculation of the difference between the highest and
lowest consumption levels of green tea, all the measured con-
sumption levels were converted to a cups-per-day scale. Each
gram of green tea consumed shown in two of the Chinese
studies was converted to 0.25 cup following the suggestion
by Mu et al. [11]. For the study by Nagano et al. [16], we
assumed one cup of green tea would be consumed at a time.
Yu et al. [17] reported the number of new batches of green
tea used. Among those who used more than four batches a
day, 12% brewed 1-3 cups per batch and 88% brewed more
than four cups per batch. The number of cups per day con-
sumed was calculated using the following equation: (0.12×
2+0.88×4)×4=15. 
To detect a possible publication bias, Begg’s funnel plot wasvisually evaluated for any asymmetry. To formally test for a
publication bias, Egger’s un-weighted regression asymmetry
test was done [18]. The funnel plot was considered to be asy-
mmetrical if the intercept of Egger’s regression line deviated
from zero with a p value of less than 0.05. 
RESULTS
Eighteen articles [11-13, 17, 19-32] were identified in the
initial search with the above mentioned method. Six articles
[16, 33-37] were identified from reference lists. Two studies
[24, 34] using a redundant dataset were excluded. Seven other
articles [12, 20, 26, 29-32] were excluded since they lacked
information on the amount of green tea intake. As a result,
fifteen articles were found to meet the inclusion criteria des-
cribed above [11-13, 16, 17, 19, 22, 23, 27, 28, 33-37]. As
three articles having gender-specific results were divided into
six independent studies [22, 28, 33], a total of 18 studies were
included in the study in the end. The selection process is shown
in Figure 1. There were seven cohort studies, one population-
based nested case-control study, and ten case-control studies.
Twelve studies were conducted among the Japanese popula-
tion in Japan, five studies were conducted among the Chinese
population in China, and the other was conducted among the
Japanese-born population in Hawaii, USA. All of the Chinese
studies were case-control studies. Table 1 presents the char-
acteristics of the studies used in the analysis.
The overall result, which is presented in Figure 2, showed
a statistically significant, 14% reduction in the risk of stomach
cancer with high green tea consumption (summary RR/OR=
0.86, 95% CI: 0.74-1.00). Table 2 presents the results of the
subgroup analyses. When stratified by country (Japan versus
China), results were homogenous among five Chinese studies
(p=0.43) with a significant risk reduction of 39% (summary
RR/OR=0.61, 95% CI: 0.47-0.81). Results from the twelve
Japanese studies were marginally homogenous (p=0.10) with
a non-significant risk reduction of 8% (summary RR/OR=0.92,
95% CI: 0.80-1.05). A statistically significant inverse associa-
tion between green tea intake and stomach cancer was obser-
ved only in the eleven case-control studies (summary RR/OR=
0.74, 95% CI: 0.63-0.86). Results from the seven cohort stud-
ies failed to support the association (summary RR/OR=1.03,
95% CI: 0.92-1.16).
When stratified by gender, the results among men were
divergent (p=0.02) while the results among women were con-
sistent (p=0.53). Neither the studies of men nor of women
showed any significant reduction in the risk (summary RR/OR=
1.00 and 0.89, 95% CI: 0.82-1.24 and 0.74-1.07, respective-
ly). When stratified by difference between the highest and
lowest green tea consumption levels, results among six stud-
ies with the difference equal to or greater than five cups/day
were homogeneous (p=0.30) with a statistically significant
risk reduction of 32% (summary RR/OR=0.68, 95% CI: 0.54-
0.85). Twelve studies with a difference of less than five cups/
day showed heterogeneous results (p=0.04) with a non-sig-
nificant risk reduction of 6% (summary RR/OR=0.94, 95%
CI: 0.81-1.10).
Figure 3 presents Begg’s funnel plot. Visual exploration of
the plot revealed an apparent asymmetry-smaller studies ten-
ded to report a protective effect of green tea while larger stud-
ies showed more mixed results. The result of Egger’s test also
supported the suspicion of publication bias (intercept=-2.02,
p=0.01).
DISCUSSION
This meta-analysis investigated the association between
green tea consumption and stomach cancer risk on the basis
of previously published researches. The overall summary RR/
OR for green tea consumption and stomach cancer risk, as
derived from eighteen observational studies, indicated a sta-
tistically significant 14% risk reduction in the high green tea
consumption group. 
The reduced risk of stomach cancer in green tea drinkers
was observed in studies with differences between the highest
and lowest daily green tea consumption levels equal to or
greater than five cups per day. Also, the studies conducted in
China showed a stronger reduction in stomach cancer among
3
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Figure 1. Flow of study selection process.4
green tea drinkers than those conducted in Japan. A few au-
thors have argued that the relative lack of subjects in Japan
who do not drink green tea may have resulted in an insuffi-
cient number of non-drinkers, and this might be an explana-
tion for the weaker associations among Japanese studies [11,
16, 38]. When a meta-analysis was done with the four Japa-
nese studies in which the difference between the highest and
lowest consumption levels was greater than five cups/day
[19, 27, 34, 37], the summary RR/OR and 95% CI were 0.72
and 0.53-0.97. This implies that if a large prospective study
with a more detailed categorization of green tea consump-
tion were performed, a protective effect of large amount of
green tea intake might be shown. This also implies that the
lack of protective effect of green tea shown in studies which
compared relatively lower level of green tea consumption
might be because of not enough intake of green tea itself. An-
other possible explanation is the difference in the production
processes among Japan and the other countries. In Japan,
Epidemiology and Health 2010;32:e2010001
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Case-control studies are population-based unless otherwise specified.
*In two cohorts reported in the article, crude RR and 95%CI were calculated from the numbers from the previously unpublished cohort 2; 
� RR/ORs were the
results of a pooled analysis of two cohorts reported in the study; 
� Crude RR/OR and 95%CI were calculated from the numbers shown in the study; 
�Crude
RR/ORs and 95%CIs were calculated from the numbers given in the study for men and women respectively.
Table 1. Characteristics of studies on green tea consumption and stomach cancer risk
Galanis DJ, 1998
[35] Cohort Hawaii, USA 108/11,799 3 None ≥2 cups/day 1.5 (0.9-2.3)
64 men 1.6 (0.9-2.9)
44 women 1.3 (0.6-2.6)
Nakachi K, 2000
[37] Cohort Saitama, Japan 140/8,412 3 ≤3 cups/day ≥10 cups/day 0.70 (0.23-1.88)
Tsubono Y, 2001
[13] Cohort Miyagi, Japan 419/25,892 4 <1 cup/day ≥5 cups/day 1.2 (0.9-1.6)
296 men 1.5 (1.0-2.1)
123 women 1.1 (0.6-2.0)
Nagano J, 2001
[16] Cohort Hiroshima & Nagasaki,  901/37,639 3 <1 time/day ≥5 times/day 0.95 (0.76-1.20)
Japan
Koizumi Y, 2003
[12] Cohort Japan 314/39,290 4 <1 cup/day ≥5 cups/day 1.19 (0.89-1.59)*
Sasazuki S, 2004
[28] Cohort Japan 892/72,051 4 <1 cup/day ≥5 cups/day
665 men 0.97 (0.77-1.22)
�
227 women 0.70 (0.47-1.05)
�
Kono S, 1988
[19] Case-control Saga, Japan 139/278 3 ≤4 cups/day ≥10 cups/day 0.36 (0.16-0.80)
�
Kato I, 1990
[33] Case-control Aichi, Japan 427/3,014 3 <1 cup/day ≥5 cups/day
Hospital based 289 men 1.01 (0.70-1.47)
138 women 0.81 (0.51-1.27)
Hoshiyama Y, 1992
[34]  Case-control Saitama, Japan 294/294 3 ≤4 cups/day ≥8 cups/day 0.8 (0.5-1.3)
Yu G, 1995
[17] Case-control Shanghai, China 711/711 3 None ≥4 new batches/day 0.54 (0.33-0.88)
453 men (≥15 cups/day) 0.53 (0.31-0.90)
258 women 0.44 (0.07-2.97)
Ji BT, 1996
[22] Case-control Shanghai, China 1,124/1,451 5 None >3000 g/yr
684 men (> 2 cups/day) 0.76 (0.55-1.27)
345 women >1200 g/yr 0.81 (0.46-1.43)
(>1 cup/day)
Inoue M, 1998
[36] Case-control Nagoya, Japan 869/21,128 5 Rarely ≥7 cups/day 0.69 (0.48-1.00)
Hospital based 613 men 0.98 (0.80-1.20)
�
280 women 1.09 (0.79-1.49)
�
Setiawan VW, 2001
[23] Case-control Yangzhong, China 132/423 3 None >21 cups/wk 0.39 (0.15-1.01)
(>3 cups/day)
Hoshiyama Y, 2004
[27] Nested case- Japan 151/265 5 <1 cup/day ≥10 cups/day 1.2 (0.6-2.5)
control
Mu LN, 2005
[11] Case-control Taixing, China 193/397 4 None ≥250 g/month 0.39 (0.17-0.91)
(≥2 cups/day)green tea production involves a steaming process at a high
temperature to retain the green color of the tea. This process
may lead to changes in chemical composition and in the con-
centrations of bioactive constituents such as vitamins C and
E, which may also contribute to the chemopreventive prop-
erties of green tea [11]. Also, the bioactivity of a cup of green
tea differs by the amount of green tea leaves used to brew it
and the frequency of renewing a tea batch in the pot [16]. Di-
fferences in tea preparation and drinking habits may, there-
fore, be a partial explanation for the differing results.
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Figure 2. Forest plot of relative risks or odds ratios from eighteen observational studies on green tea consumption and stomach can-
cer. The black squares and horizontal lines correspond to the RRs or ORs and 95% confidence intervals. The area of the black squares
reflects the weight each trial contributes to the meta-analysis. The diamond at the bottom of the graph represents the combined odds
ratio and its 95% confidence interval, indicating 14% reduction in the risk of stomach cancer. The solid vertical line corresponds to no
effect of green tea consumption (odds ratio 1.0), the dotted vertical line to the combined odds ratio (0.86). The graph was produced
in STATA. 
*Estimates of the summary RR/ORs and 95% CIs were based on either random effect model if the studies included are heterogeneous (i.e. p for hetero-
geneity is less than 0.10), or fixed effect model if the studies included are homogenous.
Characteristics  Subgroup  No. of studies
Summary RR/OR
(95% CI)*
p for
heterogeneity
Table 2. Subgroup analysis of green tea consumption and stomach cancer risk
All studies NA 18 0.86 (0.74-1.00) 0.06
Country China studies 5 0.61 (0.47-0.81) 0.43
Japan studies 12 0.92 (0.80-1.05) 0.10
Study design Case control studies 11 0.74 (0.63-0.86) 0.20
Cohort studies 7 1.03 (0.92-1.16) 0.13
Gender Males 7 1.00 (0.82-1.24) 0.02
Females 7 0.89 (0.74-1.07) 0.53
Year of publication Published before 2000 9 0.80 (0.63-1.00) 0.06
Published on and after 2000 9 0.93 (0.77-1.12) 0.06
Difference between the highest and lowest  Less than 5 12 0.94 (0.81-1.10) 0.04
consumption level 5 or more 6 0.68 (0.54-0.85) 0.306
Research design also seemed to play an important role in
the heterogeneity of effect sizes across the studies. While the
protective effect was observed among case-control studies
only, prospective studies tended to show null results. A few
prospective studies even showed increased risks with green
tea consumption although they were not statistically signifi-
cant [12, 13, 35]. Some authors suggested that tea might have
a mutagenic effect [35], but this hypothesis is contradictory
to the results of most laboratory research. The number of cases
was very small for the green tea drinkers in the report by Gal-
anis et al. [35], and that may have resulted in the exaggerat-
ed risk estimates. 
Sasazuki et al. [28] suggested that there might be a gender-
specific protective effect of green tea on stomach cancer, but
the analysis of seven studies that included gender informa-
tion revealed a statistically non-significant effect on both gen-
ders (estimates of RR/OR=1.00 for men and 0.89 for women,
95% CI: 0.82-1.24 for men, 0.74-1.07 for women). Thus,
gender does not seem to cause any difference in the effect of
green tea on stomach cancer risk.
Site-specific stomach cancer incidence in accordance with
green tea consumption was mentioned in four studies [12, 17,
22, 28]. While Ji et al. [22] and Koizumi et al. [12] showed
no difference between green tea consumption and stomach
cancer risk by anatomical subsite(data not shown), the other
two authors reported a different risk pattern by subsite. Yu et
al. [17] showed a significant protective effect for pyloric tumors
(OR= 0.29, 95% CI: 0.13-0.68), and Sasazuki et al. [28] re-
ported a significant effect for distal tumors among women
(OR=0.53, 95% CI: 0.30-0.86). Although more studies are
needed to address this issue, it is possible that green tea con-
sumption might be related to distal stomach cancers only. It
is recommended that future studies take this into considera-
tion.
Total duration of green tea drinking was considered in three
of the Chinese studies [11, 17, 23]. All of them showed a de-
creased risk of stomach cancer with increasing duration of
green tea drinking, but this result failed to reach statistical
significance (data not shown). Further studies are needed to
clarify this point. It is known that Helicobacter pylori infec-
tion is an important risk factor for a stomach cancer [1]. Only
two studies [11, 23], however, controlled for the bacteria
infection in their analyses. Green tea has been considered to
have bacteriostatic and bactericidal effects [39, 40], which
can extend to Helicobacter pylori. Thus, the infection could
have confounded the results, and further study is needed.
This meta-analysis has several limitations. First of all, pub-
lication bias cannot be ruled out. As shown in the subgroup
analysis, the protective effect of green tea was prominent
among case-control studies, which could be easily misled by
a publication bias. Because of the asymmetric funnel plot,
publication bias cannot be ruled out in this study. Second, the
research included in this study had different categories for
green tea consumption. Although the odds ratio or relative
risk of the highest consumption versus non/lowest consump-
tion was used for combining the effect size, it was not uni-
form across the studies. This might have distorted the result.
Third, the (non-English) Chinese literature could not be re-
viewed because of the language barrier. Because results from
the Chinese studies tended to show protective effects, the
combined effect would have been different if they had been
included in the study. Last, all of the studies included in the
analysis had been done among Asian populations. Green tea
is a popular drink in East Asia, while black tea is mostly con-
sumed in Western countries. The result of this study cannot
be applied to non-Asian populations.
In summary, the result of this meta-analysis suggests a pro-
tective role of green tea against stomach cancer. Subgroup
analyses revealed that the difference between the measured
highest and lowest green tea consumption level was found to
be the most prominent factor affecting the heterogeneity of
the meta-analysis. This implies that the daily consumption
level might be an important factor in determining the pre-
ventive effect of green tea against stomach cancer. Further
research focusing on higher green tea consumption level is
needed to clarify the association.
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Figure 3. Begg’s funnel plot of studies on green tea consump-
tion and stomach cancer risk. The solid line in the center is the
natural logarithm of pooled odds ratio (OR), and two oblique lines
are pseudo 95% confidence limits. 
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